亚洲社会药学

• 论文 • 上一篇    下一篇

Countermeasures of Consistency Evaluation Policy for Generic Enterprises in China

Pan Tiecheng, Zhang Fang*   

  1. School?of?Business?Administration,?Shenyang?Pharmaceutical?University,?Shenyang?110016,?China
  • 出版日期:2017-03-20 发布日期:2017-05-05

Countermeasures of Consistency Evaluation Policy for Generic Enterprises in China

Pan Tiecheng, Zhang Fang*   

  1. School?of?Business?Administration,?Shenyang?Pharmaceutical?University,?Shenyang?110016,?China
  • Online:2017-03-20 Published:2017-05-05
  • Contact: Zhang Fang, associate professor. Major research area: pharmacoeconomics, health economic policy evaluation, etc. Tel: 024-23986979, E-mail: xzhangf@126.com.

摘要: Objective To put forward some countermeasures for generic enterprises under the background of consistency evaluation policy. Methods Some measures for generic enterprises were raised on the basis of the current status analysis of generic drugs in China, together with the influence of the consistency evaluation policy on the generic drugs marketing. Results and Conclusion Generic enterprises should make the selections of generics properly and conduct R&D effectively, making full use of the supporting policies from relevant authorities to achieve the goal of consistency evaluation. Pharmaceutical enterprises in China should promote their core competitiveness, maintain full vitality in the increasingly fierce competition.

关键词: consistency evaluation, generic enterprise, countermeasure

Abstract: Objective To put forward some countermeasures for generic enterprises under the background of consistency evaluation policy. Methods Some measures for generic enterprises were raised on the basis of the current status analysis of generic drugs in China, together with the influence of the consistency evaluation policy on the generic drugs marketing. Results and Conclusion Generic enterprises should make the selections of generics properly and conduct R&D effectively, making full use of the supporting policies from relevant authorities to achieve the goal of consistency evaluation. Pharmaceutical enterprises in China should promote their core competitiveness, maintain full vitality in the increasingly fierce competition.

Key words: consistency evaluation, generic enterprise, countermeasure